About Chugai
Chugai's mission is to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- Sep 20, 2019 Chugai Obtains Approval for Additional Indication and Formulation for Tecentriq in PD-L1-Positive Triple Negative Breast Cancer
- Sep 18, 2019 Chugai Selected for the Fifth Time and 2nd Consecutive Year for Dow Jones Sustainability Asia Pacific Index
- Sep 13, 2019 Chugai Receives Orphan Drug Designation for Satralizumab in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder from the Ministry of Health, Labour and Welfare
- Sep 12, 2019 Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab in NMOSD at ECTRIMS 2019
- Sep 09, 2019 Chugai’s Disease Awareness Website “Let’s Learn about Rheumatoid Arthritis” Adopts FACIL’iti to Enhanse Accessibility
-
Diversity and Inclusion Initiatives
Find information on our initiatives to promote work-life balance and diverse human resources, and performance data for topics such as the ratio of female employees.
-
Engagement with Employees
Chugai promotes engagement with employees by conducting talent management according to each person's capabilities and aptitude, providing systems that help our diverse people to succeed, and creating supportive work environments.
For more information
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Biology Lab Classes for Children Held (2018)
-
Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge
-
Chugai to Take Part in Relay for Life Japan 2018
